1203902-67-3

4-Ethyl-N-[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]-1-piperazinecarboxamide is a drug candidate and it is used in the preparation of quinazolinediamine derivatives as EGFR inhibitors useful in the treatment of cancer.